# Rocio Pillado

> Rocio Pillado is a Series A investor at Adara Ventures backing Health Care and Health Diagnostics. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Adara Ventures](https://shizune.co/investors/profile/adara-venture-partners)
- Location: Madrid, Spain
- Total investments: 6
- Last investment: Jul 2025
- Lead investor: 83%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/rociopillado/
- X (Twitter): https://twitter.com/ropillado

Rocio Pillado is a Series A investor at Adara Ventures in Madrid focused on Health Care and Health Diagnostics. Rocío joined Adara in 2013 after finishing her MBA at The University of Chicago Booth School of Business. Before Adara, Rocío worked at Société Générale Corporate & Investment Banking (SGCIB) within the Trading & Sales department, in the New York and Hong Kong offices. She worked as a project leader and software engineer, designing andbuilding trading software. Previously, Rocío worked in France in the security field, both as a consultant and as an engineer. She worked in projects related to system security and monitoring, secure software for smart cards, and database availability. Rocío is also the co-founder of Club-MBA.com, the leading website in the Spanish language about MBA and other graduate programs.Rocío holds an engineering degree in Computer Science from the Universidad Politécnica de Madrid and another from the École Nationale Supérieure d'Informatique et de Mathématiques Appliquées (ENSIMAG). She also holds an MSc in Cryptology, Security and Information Coding from the Institut Fourier.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 33% |
| Health Diagnostics | 2 | 33% |
| Artificial Intelligence | 2 | 33% |
| EdTech | 1 | 17% |
| Medical | 1 | 17% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 50% |
| Seed | 2 | 33% |
| Funding Round | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TuringDream | TuringDream redefines education. Deeply personal, broadly available, and substantially cheaper. | $7.1M | Seed | Jul 02, 2025 |  |
| indigitall | indigitall the mission to help its Customers in their digital transformation and to improve user experience through value added solutions in mobility. Ever since, indigitall has developed a unique global solution that enables its Customers to establish enriched, personalised and segmented communication with its users through their mobileapplications and/or websites. Their vision is to be one of the leading global platforms in automated marketing. The key to their differentiation is the continuous commitment to their solution’s INNOVATION and FLEXIBILITY and to their Customers’ specific needs. indigitall already has a presence in Spain, Italy, Colombia and Mexico, with the short-term goal of establishing itself in other countries. | $6.4M | Series A | Apr 23, 2024 |  |
| WIVI Vision | visual+cognitive enhancement | $4.3M | Series A | Feb 19, 2024 |  |
| IOMED | IOMED Medical Solutions develops a medical record management software aimed at structuring clinical data and the generation of artificial intelligence tools.A technology, based on Natural Language Processing, that allows structure clinical text, obtaining reusable data for the development of medical predictive models. It saves costs andeffectively assigns resources by extracting insights from a hospital's clinical notes and data management. The company's software uses artificial intelligence and cognitive computing to organize and visualize medical records information and offers data structuring, integration, and interoperability, providing clinicians with efficiency, information, and savings needed to make more efficient decisions.Alvaro Abella, Gabriel de Maeztu, and Javier Oca founded the company in Barcelona, Catalonia in 2016. | $11M | Series A | Sep 12, 2023 |  |
| IOMED | IOMED Medical Solutions develops a medical record management software aimed at structuring clinical data and the generation of artificial intelligence tools.A technology, based on Natural Language Processing, that allows structure clinical text, obtaining reusable data for the development of medical predictive models. It saves costs andeffectively assigns resources by extracting insights from a hospital's clinical notes and data management. The company's software uses artificial intelligence and cognitive computing to organize and visualize medical records information and offers data structuring, integration, and interoperability, providing clinicians with efficiency, information, and savings needed to make more efficient decisions.Alvaro Abella, Gabriel de Maeztu, and Javier Oca founded the company in Barcelona, Catalonia in 2016. | $2.2M |  | Sep 03, 2020 |  |
| Quibim | Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading pharmaceutical companies and research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy ofnovel treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers. We understand every body part. We speak human. | $9.2M | Seed | Jul 21, 2020 |  |

6 of 6 investments shown.

## Co-investors
- [EASO Ventures](https://shizune.co/investors/profile/easo-ventures) — VC Fund, 2 deals together
- [Amadeus Capital Partners](https://shizune.co/investors/profile/amadeus-capital-partners) — VC Fund, 1 deal together
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund, 1 deal together
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-12df) — VC Fund, 1 deal together
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-2) — VC Fund, 1 deal together
- [Avançsa](https://shizune.co/investors/profile/avancsa) — VC Fund, 1 deal together

## About Adara Ventures

VC Fund · Luxembourg, Luxembourg

Adara Ventures invests in ambitious businesses, partnering with founders with the capacity, courage, and vision to execute. In the last 18 years, the firm has invested in 43 companies and manages €200m. Focused on early-stage companies and with a European footprint, Adara’s portfolio includes companies dedicated to cybersecurity, data applicationsand infrastructure, DevOps, hardware components, digital health, and the energy transition. For more information, visit www.adara.vc

5 contacts available at Adara Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Monica Navas | Head of Investor Relations | https://shizune.co/investors/profile/monica-navas |
| Nicolas Goulet | Managing Partner | https://shizune.co/investors/profile/nicolas-goulet |
| Rocio Pillado | Partner | https://shizune.co/investors/profile/rocio-pillado-lopez |
| Ross Strachan | Partner | https://shizune.co/investors/profile/ross-strachan |
| Alberto Gomez | Managing Partner | https://shizune.co/investors/profile/alberto-gomez |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Rocio Pillado invest in?

Rocio Pillado invests primarily in Health Care, Health Diagnostics and Artificial Intelligence startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Rocio Pillado last invest?

The most recent investment recorded for Rocio Pillado closed in Jul 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co